Your session is about to expire
← Back to Search
transcranial magnetic stimulation for Transcranial Magnetic Stimulation
Study Summary
This trial looks at whether TMS can help improve symptoms in people with schizophrenia by stimulating the prefrontal and posterior parietal cortex.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this experiment currently enrolling participants?
"Correct. The information found on clinicaltrials.gov confirms that this medical research, which was first posted on July 23rd 2021, is actively searching for volunteers. Approximately 40 patients will be recruited from two distinct centres."
How many participants are the maximum number that can take part in this investigation?
"Affirmative. According to clinicaltrials.gov, the study was launched on July 23rd 2021 and edited November 9th 2022; actively recruiting 40 patients over two different sites."
Is the eligibility criteria of this experiment inclusive to those aged 35 and up?
"According to the requirements, suitable applicants for this medical experiment should be between 18 and 30 years old. Separately, there are 1 studies designed specifically for individuals under 18 and 13 trials that are aimed at those over 65."
What criteria must patients meet in order to participate in this clinical trial?
"Patients aged 18 to 30 with transcranial magnetic stimulation (TMS) can participate in this investigation. Furthermore, applicants must be right-handed and have been a native English speaker or fluent by the age of six for eligibility."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger